Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine

T. Tsuchihashi, A. Tsukashima, K. Matsumura, I. Abe, M. Tominaga, Y. Nakao, K. Kobayashi, M. Fujishima

研究成果: ジャーナルへの寄稿記事

4 引用 (Scopus)

抄録

A newly developed calcium antagonist, nilvadipine, was administered to 7 hypertensive patients aged 75.6 y. Nilvadipine 4 mg b.d. decreased the average 24-h blood pressure significantly from 169/89 mm Hg to 152/81 mm Hg after 7 to 14 days without any change in the pulse rate. The circadian patterns of blood pressure and pulse rate were not affected by nilvadipine. Although the present study was a preliminary one done over a short period in a small number of patients, the results suggest that nilvadipine exerts an antihypertensive effect without altering the circadian pattern or the variability of blood pressure in elderly hypertensive patients.

元の言語英語
ページ(範囲)255-257
ページ数3
ジャーナルEuropean Journal of Clinical Pharmacology
41
発行部数3
DOI
出版物ステータス出版済み - 9 1 1991

Fingerprint

nilvadipine
Ambulatory Blood Pressure Monitoring
Calcium
Blood Pressure
Heart Rate
Antihypertensive Agents

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

これを引用

Tsuchihashi, T., Tsukashima, A., Matsumura, K., Abe, I., Tominaga, M., Nakao, Y., ... Fujishima, M. (1991). Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine. European Journal of Clinical Pharmacology, 41(3), 255-257. https://doi.org/10.1007/BF00315439

Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine. / Tsuchihashi, T.; Tsukashima, A.; Matsumura, K.; Abe, I.; Tominaga, M.; Nakao, Y.; Kobayashi, K.; Fujishima, M.

:: European Journal of Clinical Pharmacology, 巻 41, 番号 3, 01.09.1991, p. 255-257.

研究成果: ジャーナルへの寄稿記事

Tsuchihashi, T, Tsukashima, A, Matsumura, K, Abe, I, Tominaga, M, Nakao, Y, Kobayashi, K & Fujishima, M 1991, 'Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine', European Journal of Clinical Pharmacology, 巻. 41, 番号 3, pp. 255-257. https://doi.org/10.1007/BF00315439
Tsuchihashi, T. ; Tsukashima, A. ; Matsumura, K. ; Abe, I. ; Tominaga, M. ; Nakao, Y. ; Kobayashi, K. ; Fujishima, M. / Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine. :: European Journal of Clinical Pharmacology. 1991 ; 巻 41, 番号 3. pp. 255-257.
@article{839f229b6d2c4b0aa569bfc41bf843ef,
title = "Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine",
abstract = "A newly developed calcium antagonist, nilvadipine, was administered to 7 hypertensive patients aged 75.6 y. Nilvadipine 4 mg b.d. decreased the average 24-h blood pressure significantly from 169/89 mm Hg to 152/81 mm Hg after 7 to 14 days without any change in the pulse rate. The circadian patterns of blood pressure and pulse rate were not affected by nilvadipine. Although the present study was a preliminary one done over a short period in a small number of patients, the results suggest that nilvadipine exerts an antihypertensive effect without altering the circadian pattern or the variability of blood pressure in elderly hypertensive patients.",
author = "T. Tsuchihashi and A. Tsukashima and K. Matsumura and I. Abe and M. Tominaga and Y. Nakao and K. Kobayashi and M. Fujishima",
year = "1991",
month = "9",
day = "1",
doi = "10.1007/BF00315439",
language = "English",
volume = "41",
pages = "255--257",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine

AU - Tsuchihashi, T.

AU - Tsukashima, A.

AU - Matsumura, K.

AU - Abe, I.

AU - Tominaga, M.

AU - Nakao, Y.

AU - Kobayashi, K.

AU - Fujishima, M.

PY - 1991/9/1

Y1 - 1991/9/1

N2 - A newly developed calcium antagonist, nilvadipine, was administered to 7 hypertensive patients aged 75.6 y. Nilvadipine 4 mg b.d. decreased the average 24-h blood pressure significantly from 169/89 mm Hg to 152/81 mm Hg after 7 to 14 days without any change in the pulse rate. The circadian patterns of blood pressure and pulse rate were not affected by nilvadipine. Although the present study was a preliminary one done over a short period in a small number of patients, the results suggest that nilvadipine exerts an antihypertensive effect without altering the circadian pattern or the variability of blood pressure in elderly hypertensive patients.

AB - A newly developed calcium antagonist, nilvadipine, was administered to 7 hypertensive patients aged 75.6 y. Nilvadipine 4 mg b.d. decreased the average 24-h blood pressure significantly from 169/89 mm Hg to 152/81 mm Hg after 7 to 14 days without any change in the pulse rate. The circadian patterns of blood pressure and pulse rate were not affected by nilvadipine. Although the present study was a preliminary one done over a short period in a small number of patients, the results suggest that nilvadipine exerts an antihypertensive effect without altering the circadian pattern or the variability of blood pressure in elderly hypertensive patients.

UR - http://www.scopus.com/inward/record.url?scp=0025820573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025820573&partnerID=8YFLogxK

U2 - 10.1007/BF00315439

DO - 10.1007/BF00315439

M3 - Article

C2 - 1748143

AN - SCOPUS:0025820573

VL - 41

SP - 255

EP - 257

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 3

ER -